Literature DB >> 24796384

Spiradenocarcinoma, cylindrocarcinoma and spiradenocylindrocarcinoma: a clinicopathological study of nine cases.

Bo Dai1, Yun-Yi Kong, Xu Cai, Xu-Xia Shen, Jin-Cheng Kong.   

Abstract

AIMS: To elucidate diagnostic criteria for spiradenocarcinoma, cylindrocarcinoma and spiradenocylindrocarcinoma, and to emphasize correlations between clinical behaviour and variable morphological patterns. METHODS AND
RESULTS: We investigated the clinicopathological and immunophenotypic features of nine cases. There were five men and four women, with ages ranging from 58 years to 82 years. The tumour size varied from 10 mm to 50 mm. The head and neck were most commonly involved. Three cases of spiradenocarcinoma and three cases of cylindrocarcinoma showed a salivary gland-type basal cell adenocarcinoma-like pattern, low-grade (BCAC-LG) and/or high grade (BCAC-HG). The remaining three cases of spiradenocarcinoma showed adenocarcinoma in situ, with invasive adenocarcinoma being seen in one of these cases. PAS staining revealed loss of the PAS-positive hyaline sheath in malignant zones of cylindrocarcinoma. p53 staining was variably positive in the malignant components of all cases. Follow-up was available for all patients, ranging from 5 months to 107 months. Two patients died of disease, one experienced recurrence, and one died of an unrelated cause.
CONCLUSIONS: Patients with BCAC-LG have a better prognosis. BCAC-HG is more likely to be found in cylindrocarcinoma, and its clinical behaviour seems to be more aggressive. Close follow-up for early detection of recurrence and metastases is strongly recommended.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  cylindrocarcinoma; immunohistochemistry; prognosis; spiradenocarcinoma

Mesh:

Substances:

Year:  2014        PMID: 24796384     DOI: 10.1111/his.12448

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Morphologically low-grade spiradenocarcinoma: a clinicopathologic study of 19 cases with emphasis on outcome and MYB expression.

Authors:  Michiel P J van der Horst; Zlatko Marusic; Jason L Hornick; Boštjan Luzar; Thomas Brenn
Journal:  Mod Pathol       Date:  2015-04-10       Impact factor: 7.842

2.  Malignant cylindroma in a patient with Brooke-Spiegler syndrome.

Authors:  Liliane Borik; Patricia Heller; Monica Shrivastava; Viktoryia Kazlouskaya
Journal:  Dermatol Pract Concept       Date:  2015-04-30

3.  ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.

Authors:  Mamunur Rashid; Michiel van der Horst; Thomas Mentzel; Francesca Butera; Ingrid Ferreira; Alena Pance; Arno Rütten; Bostjan Luzar; Zlatko Marusic; Nicolas de Saint Aubain; Jennifer S Ko; Steven D Billings; Sofia Chen; Marie Abi Daoud; James Hewinson; Sandra Louzada; Paul W Harms; Guia Cerretelli; Carla Daniela Robles-Espinoza; Rajiv M Patel; Louise van der Weyden; Chris Bakal; Jason L Hornick; Mark J Arends; Thomas Brenn; David J Adams
Journal:  Nat Commun       Date:  2019-05-17       Impact factor: 14.919

Review 4.  Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.

Authors:  Iga Płachta; Marcin Kleibert; Anna M Czarnecka; Mateusz Spałek; Anna Szumera-Ciećkiewicz; Piotr Rutkowski
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.